| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO | Director, Senior Advisor +1 more
1 company
Christopher Posner last filed a Form 4 in February 2025, as President and CEO at TVRD. From June 2019 to February 2025, the filings on record show 0 open-market purchases and 17 sales. Christopher Posner's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Christopher Posner's trades have earned a strong insider score of 80/100 across 16 rated trades. Over a 12-month horizon, 93.8% of those trades were profitable, with an average 12-month return of +51.8%.
At the last filing, the largest reported position was 13,109 shares of TVRD. The TVRD filings lean toward selling, a net 102,028 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2023 | TVRD Tvardi Therapeutics, Inc. | President and CEO | Sell10b5-1 | 3,869 | $4.40 | $17,023.60 | -2.2% | -27.3% | -82.3% | |
| Mar 3, 2023 | TVRD Tvardi Therapeutics, Inc. | President and CEO | Sell | 5,987 | $9.71 | $58,133.77 | -3.3% | -69.9% | -90.8% | |
| Feb 2, 2023 | TVRD Tvardi Therapeutics, Inc. | President and CEO | Sell | 4,191 | $11.80 | $49,453.80 | -2.2% | -64.8% | -95.2% | |
| Nov 16, 2022 | TVRD Tvardi Therapeutics, Inc. | President and CEO | Sell | 14,470 | $11.13 | $161,051.10 | -7.2% | -4.2% | -90.2% | |
| Apr 4, 2022 | TVRD Tvardi Therapeutics, Inc. | President and CEO | Sell | 2,006 | $12.67 | $25,416.02 | -1.0% | -26.6% | -62.3% | |
| Jun 7, 2021 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 2,304 | $13.04 | $30,044.16 | -12.5% | +16.0% | -34.1% | |
| Nov 19, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 2,000 | $15.82 | $31,638.00 | -15.2% | - | - |